Louisiana · 2026 Regular Session · Bill
HB 920: INSURANCE/HEALTH: Requires drug manufacturers to limit pricing of GLP-1 medications for health insurance plans (OR INCREASE GF EX See Note)
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 920 is a bill introduced in the Louisiana House on February 27, 2026. According to its official title, it concerns: INSURANCE/HEALTH: Requires drug manufacturers to limit pricing of GLP-1 medications for health insurance plans (OR INCREASE GF EX See Note). Primary sponsor: Edmond Jordan (Democratic). Most recent recorded action (March 9, 2026): Read by title, under the rules, referred to the Committee on Insurance.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Edmond Jordan | Primary sponsor | Democratic | House | 29 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Read by title, under the rules, referred to the Committee on Insurance.
- Prefiled.
- Under the rules, provisionally referred to the Committee on Insurance.
- First appeared in the Interim Calendar on 2/27/2026.